O'DAY DANIEL PATRICK (Chairman & CEO) sold 1.5% of their position (10K shares) of GILEAD SCIENCES, INC. on the open market
Open‑market sale worth $1.45M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/2/2026ACC: 0001638643-26-000012
DirectorOfficer· Chairman & CEO
Since Feb 2019
+28.40K
Net shares
Net buyer
$1.45M
Total sold
3
Open market trades
0B · 3S
4
Total transactions
38.40K acquired · 10K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+38.40K
Price / share
—
Trade value
—
% of position
6.3%
2/27/2026
613.91K→652.31K
Common Stock
Direct
Shares
−3.48K
Price / share
$144.04
Trade value
$501.39K
% of position
0.5%
2/27/2026
652.31K→648.83K
Common Stock
Direct
Shares
−6.42K
Price / share
$145.18
Trade value
$931.90K
% of position
1.0%
2/27/2026
648.83K→642.41K
Common Stock
Direct
Shares
−100.00
Price / share
$145.71
Trade value
$14.57K
% of position
0.0%
2/27/2026
642.41K→642.31K
Total
Net shares
+28.40K
Net value
-$1.45M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/27/2026 | A · Award | +38.40K | — | — | 6.3% | 613.91K | 652.31K |
| Common Stock Direct | 2/27/2026 | S · Sale | −3.48K | $144.04 | $501.39K | 0.5% | 652.31K | 648.83K |
| Common Stock Direct | 2/27/2026 | S · Sale | −6.42K | $145.18 | $931.90K | 1.0% | 648.83K | 642.41K |
| Common Stock Direct | 2/27/2026 | S · Sale | −100.00 | $145.71 | $14.57K | 0.0% | 642.41K | 642.31K |
| Total | +28.40K | -$1.45M | ||||||
Derivative Transactions0
No derivative transactions reported